MRGPRX2 and anaphylaxis: While clinical features of MRGPRX2-mediated reactions can mimic IgE-mediated anaphylaxis, certain features may favor the former—such as reactions occurring on first exposure, the need for higher doses to trigger symptoms, and shorter symptom duration [13].